Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia
Sponsor: Mohamed Sayed Abdelhafez
A observational or N/A phase clinical study on Preeclampsia, this trial is completed. The trial is conducted by Mohamed Sayed Abdelhafez and has accumulated 15 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Dec 2021 — Nov 2023 [monthly]
Unknown Status
▶ Show 10 earlier versions
-
Nov 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jun 2019 — Nov 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mohamed Sayed Abdelhafez
For direct contact, visit the study record on ClinicalTrials.gov .